» Download Public Reports
84 reports
- Country report
- August 2012
- 3 pages
... Witnessed qualitative and quantitative growth stemming from population aging and increase in chronic diseases. However, the industry is likely to experience slowing growth as downward pressure on drug ...
November 2012
... Companies are faced with many challenges such as drug price reductions and market share erosion by multinational companies. Nonetheless, we reiterate our overweight rating on the pharmaceutical sector ...
October 2012
... Based crystalgenomics to support the development of active pharmaceutical ingredients (apis) for next-generation non- steroidal anti-inflammatory drugs (nsaid). The agreement represents safc's premier pre ...
November 2012
... As belviq or under a different trade name, we use belviq in this report to refer to the finished drug product for lorcaserin hydrochloride or, depending on the context, lorcaserin hydrochloride or other ...
June 2012
... In government-led r&d projects tax support expand corporate income tax exemption related to r&d costs Proprietary technology: include phase i & ii clinical trials New growth engines: include vaccines ...
July 2012
... To ice how does the interest between the government and the medical industry conflict Do you think that the nation S drug market suffers from over- competition resulting in the lack of profit ...
July 2012
... Total number of countries expected to co-finance and co-financing amount paid by countries* projected vaccine costs as a share of projected public spending on health, 2015 vaccines < 1 percent ...
January 2013
... For h5n1 vaccines for risk groups Government to engage producer(s) into veterinary vaccine production Niche market for h5n1. Who-hhs meeting on business models, dc, jan 2013 5 ...
July 2012
... Metals, such as lead and mercury in herbal medicines. This kit relies on an advanced and highly- sensitive enzymatic assay. Business idea to design, develop, produce and distribute a commercial scale ...
» Purchase Premium Reports
(From $ 250 - $ 613)
61 reports
- $ 652
- Industry report
- May 2013
- by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in South Korea. The study provides essential market information for decision-makers ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 300
Summary Ildong Pharmaceutical Co., Ltd. (Ildong Pharmaceutical) is a Korea-based pharmaceutical company engaged in the production of pharmaceutical specialties, pharmaceutical raw materials, and environmental ...
March 2013
$ 250
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 250
Summary Ildong Pharmaceutical Co., Ltd. (Ildong Pharmaceutical) is a Korea-based pharmaceutical company engaged in the production of pharmaceutical specialties, pharmaceutical raw materials, and environmental ...
March 2013
$ 250
Summary Hwail Pharma Co., Ltd. (Hwail Pharma) is a pharmaceutical and healthcare company, based in Republic of Korea. The company manufactures markets and exports active pharmaceutical ingredients, pharmaceutical ...
March 2013
$ 250
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
